Erişkin T-hücreli Lösemi/Lenfomalı Hemodiyaliz Hastasında Mogamulizumab Tedavisi

Journal Title: Turkish Journal of Hematology - Year 2014, Vol 31, Issue 4

Abstract

Authors and Affiliations

Mari Yoshihara, Yasushi Kubota, Makoto Fukuda, Tomoya Kishi, Yuji Ikeda, Shinya Kimura

Keywords

Related Articles

TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms

We aimed to determine the genotype distribution, allele frequency, and prognostic impact of IDH1/2, TET2, and ASXL1 single nucleotide polymorphisms (SNPs) in myeloproliferative neoplasms (MPNs). TET2 (rs763480), ASXL1 (r...

Health-Related Quality of Life, Depression, Anxiety, and Self-Image in Acute Lymphocytic Leukemia Survivors

Objective: With increasing survival rates in childhood acute lymphocytic leukemia (ALL), the long-term side effects of treatment have become important. Our aim was to investigate health-related quality of life, depressio...

Download PDF file
  • EP ID EP116644
  • DOI 10.4274/tjh.2014.0166
  • Views 94
  • Downloads 0

How To Cite

Mari Yoshihara, Yasushi Kubota, Makoto Fukuda, Tomoya Kishi, Yuji Ikeda, Shinya Kimura (2014). Erişkin T-hücreli Lösemi/Lenfomalı Hemodiyaliz Hastasında Mogamulizumab Tedavisi. Turkish Journal of Hematology, 31(4), 424-425. https://europub.co.uk/articles/-A-116644